Asthma inhaler 'step-down' may be unnecessary
Key points
- Starting people with moderate asthma on a high dose of the inhaled steroid fluticasone and then stepping down to a low dose is no more effective than starting with at a low fixed dose, according to a study conducted in Italy.
- "Our results, together with previous findings, strongly suggest that the step-down or 'hit-hard' approach may not be necessary in patients with mild-to-moderate asthma" to control inflammation, Dr.
- Foresi's team randomly assigned 35 such patients to start inhaled fluticasone propionate at 1000 micrograms per day and then to reduce the dose to 200 micrograms per day, or to start treatment at a fixed-dose of 200 micrograms.
- The investigators report that both approaches reduced bronchial hyperresponsiveness and airway inflammation to a similar degree.
Starting people with moderate asthma on a high dose of the inhaled steroid fluticasone and then stepping down to a low dose is no more effective than starting with at a low fixed dose, according to a study conducted in Italy.
"Our results, together with previous findings, strongly suggest that the step-down or 'hit-hard' approach may not be necessary in patients with mild-to-moderate asthma" to control inflammation, Dr. Antonio Foresi from Sesto San Giovanni Hospital and colleagues write in the journal Chest.
Foresi's team randomly assigned 35 such patients to start inhaled fluticasone propionate at 1000 micrograms per day and then to reduce the dose to 200 micrograms per day, or to start treatment at a fixed-dose of 200 micrograms.
The investigators report that both approaches reduced bronchial hyperresponsiveness and airway inflammation to a similar degree.
Moreover, 8 weeks after stopping fluticasone, markers of inflammation remained in the normal range in 30 percent of patients in both groups.
Fluticasone is the steroid used in Advair and Flovent inhalers made by Glaxo, which provided a grant for the study.
SOURCE: Chest, January 2005.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Lungs, Asthma & Allergies →NewsTime to rethink the inner-city asthma epidemic?
Challenging the long-standing belief that city dwellers suffer disproportionately from asthma, the results of a new Johns Hopkins Children's Center study of more than 23,000 U.S. children reveal that income, race and…
21 January 2015
NewsRare mutations do not explain 'missing heritability' in asthma
Despite a strong suspected link between genetics and asthma, commonly found genetic mutations account for only a small part of the risk for developing the disease - a problem known as missing heritability. Rare and low…
20 January 2015
NewsCausal link between antibiotics and childhood asthma dismissed
In a new register study in the scientific journal BMJ, researchers at Karolinska Institutet are able to dismiss previous claims that there is a link between the increased use of antibiotics in society and a coinciding…
